SCHEMBL6016878

SCHEMBL6016878

CN(CC(=O)NC1CCCC1)c1[c]c(Cl)nc(Cc2ccc(NCC3CCCCC3)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
POLB P06746 1/20 0.38
EPHX2 P34913 2/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 2/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
MAPT P10636 1/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MDM2 Q00987 1/20 0.34
NPY5R Q15761 1/20 0.34
CRHR1 P34998 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5961317 0.89 EPHX2 (0.41) GAAPOLBEPHX2NPC1RAB9A
SCHEMBL6016869 0.86 GAA (0.40) GAAPOLBEPHX2SMN1; SMN2TSHR
SCHEMBL5961320 0.84 EPHX1 (0.41) GAAEPHX2ALDH1A1SMN1; SMN2TSHR
SCHEMBL6017031 0.83 GAA (0.42) GAAPOLBALDH1A1SMN1; SMN2NPC1
SCHEMBL5961338 0.83 TBXA2R (0.40) POLBALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5961348 0.82 HDAC1 (0.43) GAAPOLBSMN1; SMN2NPC1RAB9A
SCHEMBL6016968 0.82 ACKR3 (0.40) GAAEPHX2SMN1; SMN2AURKBMEN1
SCHEMBL5961316 0.81 EPHX1 (0.42) HPGD
SCHEMBL5961345 0.81 ACKR3 (0.42) POLBSMN1; SMN2NPC1RAB9AMAPT
SCHEMBL6016975 0.80 EPHX2 (0.43) GAAPOLBEPHX2SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633726-A1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 Actimis Pharmaceuticals, Inc., (US) 2006-03-15 EP disclosed
WO-2004096777-A1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 ACTIMIS PHARMACEUTICALS, INC. (US) 2004-11-11 WO disclosed